hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway
The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
hTERT is the catalytic subunit of the telomerase and is hence required for telomerase maintenance activity and cancer cell immortalization. Here, we show that acute hTERT depletion has no adverse effects on the viability or proliferation of cervical and colon carcinoma cell lines, as evaluated within 72 h after transfection with hTERT-specific small interfering RNAs (siRNAs). Within the same time frame, hTERT depletion facilitated the induction of apoptotic cell death by cisplatin, etoposide, mitomycin C and reactive oxygen species, yet failed to sensitize cells to death induction via the CD95 death receptor. Experiments performed with p53 knockout cells or chemical p53 inhibitors revealed that p53 was not involved in the chemosensitizing effect of hTERT knockdown. However, the proapoptotic Bcl-2 family protein Bax was involved in cell death induction by hTERT siRNAs. Depletion of hTERT facilitated the conformational activation of Bax induced by genotoxic agents. Moreover, Bax knockout abolished the chemosensitizing effect of hTERT siRNAs. Inhibition of mitochondrial membrane permeabilization by overexpression of Bcl-2 or expression of the cytomegalovirus-encoded protein vMIA (viral mitochondrial inhibitor of apoptosis), which acts as a specific Bax inhibitor, prevented the induction of cell death by the combination of hTERT depletion and chemotherapeutic agents. Altogether, our data indicate that hTERT inhibition may constitute a promising strategy for facilitating the induction of the mitochondrial pathway of apoptosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, hTERT protein acts on mitochondria to inhibit the intrinsic pathway of apoptosis, 129”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [129]
In the citing paper
“and interacts with chromatin remodeling factors (such as SMARCA4) and transcription factors (such as NF-kB) to transactivate genes involved in tumor progression.129”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [129]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“…inactivate the p53 pathway that links the DNA-damage response to mitochondrial apoptosis, either through transcriptional effects of p53 or owing to a physical interaction of p53 with proapoptotic members of the Bcl-2 family (Vogelstein et al., 2000; Vousden and Lu, 2002; Perfettini et al., 2004).”
BackgroundDanial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., & Riccardi, C. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90198-o · Cited by 4,579
The Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,418
Self-citationLive or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Switching and Signaling at the Telomere
Blackburn, E. H. (2001) · Cell · doi:10.1016/s0092-8674(01)00492-5 · Cited by 2,107
Movement of Bax from the Cytosol to Mitochondria during Apoptosis
Wolter, K. G., Hsu, Y.-T., Smith, C. L., Nechushtan, A., Xi, X.-G., & Youle, R. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.5.1281 · Cited by 1,806
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270
Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssière, J. L., Petit, P. X., & Kroemer, G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1661 · Cited by 1,166
Self-citation
Cited by
Targeting telomeres and telomerase
De Cian, A., Lacroix, L., Douarre, C., Temime-Smaali, N., Trentesaux, C., Riou, J.-F., & Mergny, J.-L. (2008) · Biochimie · doi:10.1016/j.biochi.2007.07.011 · Cited by 572
Meta-hallmarks of aging and cancer
López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L., & Kroemer, G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.001 · Cited by 529
Self-citationAhmed, S., Passos, J. F., Birket, M. J., Beckmann, T., Brings, S., Peters, H., Birch-Machin, M. A., von Zglinicki, T., & Saretzki, G. (2008) · Journal of Cell Science · doi:10.1242/jcs.019372 · Cited by 491
Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins
Martínez, P., & Blasco, M. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3025 · Cited by 468
DNA damage in telomeres and mitochondria during cellular senescence: is there a connection?
Passos, J. F., Saretzki, G., & von Zglinicki, T. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm893 · Cited by 344
Mitochondrial gateways to cancer
Galluzzi, L., Morselli, E., Kepp, O., Vitale, I., Rigoni, A., Vacchelli, E., Michaud, M., Zischka, H., Castedo, M., & Kroemer, G. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.08.002 · Cited by 300
Self-citationSenescence, Apoptosis or Autophagy?
Vicencio, J. M., Galluzzi, L., Tajeddine, N., Ortiz, C., Criollo, A., Tasdemir, E., Morselli, E., Ben Younes, A., Maiuri, M. C., Lavandero, S., et al. (2008) · Gerontology · doi:10.1159/000129697 · Cited by 261
Self-citationIndran, I. R., Hande, M. P., & Pervaiz, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1588 · Cited by 256
Actions of human telomerase beyond telomeres
Cong, Y., & Shay, J. W. (2008) · Cell Research · doi:10.1038/cr.2008.74 · Cited by 229
Extra-telomeric Functions of Human Telomerase: Cancer, Mitochondria and Oxidative Stress
Saretzki, G. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140630095606 · Cited by 156
Listerman, I., Sun, J., Gazzaniga, F. S., Lukas, J. L., & Blackburn, E. H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3082 · Cited by 159
Xie, Y., Qiao, H., Su, Z., Chen, M., Ping, Q., & Sun, M. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.068 · Cited by 156
TERT promotes cellular and organismal survival independently of telomerase activity
Lee, J., Sung, Y. H., Cheong, C., Choi, Y. S., Jeon, H. K., Sun, W., Hahn, W. C., Ishikawa, F., & Lee, H.-W. (2008) · Oncogene · doi:10.1038/sj.onc.1211037 · Cited by 145
Ets2 Maintains hTERT Gene Expression and Breast Cancer Cell Proliferation by Interacting with c-Myc
Xu, D., Dwyer, J., Li, H., Duan, W., & Liu, J.-P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800790200 · Cited by 142
Telomerase, mitochondria and oxidative stress
Saretzki, G. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.05.004 · Cited by 128
Molecular mechanisms of brain-derived neurotrophic factor in neuro-protection: Recent developments
Zhao, H., Alam, A., San, C.-Y., Eguchi, S., Chen, Q., Lian, Q., & Ma, D. (2017) · Brain Research · doi:10.1016/j.brainres.2017.03.029 · Cited by 122
Identification of T-cell epitopes for cancer immunotherapy
Kessler, J. H., & Melief, C. J. M. (2007) · Leukemia · doi:10.1038/sj.leu.2404787 · Cited by 125
Tsai, Y., Chiu, C., Chen, J. Y., Chan, K., & Lin, S. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.08.032 · Cited by 103
Telomerase and drug resistance in cancer
Lipinska, N., Romaniuk, A., Paszel-Jaworska, A., Toton, E., Kopczynski, P., & Rubis, B. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2573-2 · Cited by 97
Chung, J., Khadka, P., & Chung, I. K. (2012) · Journal of Cell Science · doi:10.1242/jcs.099267 · Cited by 97
Regulation of apoptosis-inducing factor-mediated, cisplatin-induced apoptosis by Akt
Yang, X., Fraser, M. E., Abedini, M. R., Bai, T., & Tsang, B. K. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604223 · Cited by 100
Non-canonical functions of Telomerase Reverse Transcriptase – Impact on redox homeostasis
Rosen, J., Jakobs, P., Ale‐Agha, N., Altschmied, J., & Haendeler, J. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101543 · Cited by 103
Curcumin and Silibinin Inhibit Telomerase Expression in T47D Human Breast Cancer Cells
Nasiri, M., Zarghami, N., Nejati‐Koshki, K., Mollazadeh, M., Pourhassan‐Moghaddam, M., Yamchi, M. R., Jahanban‐Esfahlan, R., Barkhordari, A., & Alibakhshi, A. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.6.3449 · Cited by 84
Ip, F. C. F., Ng, Y. P., An, H. J., Ying, D., Pang, H. H., Hu, Y., Chin, A. C., Harley, C. B., Wong, Y. H., & Ip, N. Y. (2014) · Neurosignals · doi:10.1159/000365290 · Cited by 89
Terrin, L., Col, J. D., Rampazzo, E., Zancai, P., Pedrotti, M., Ammirabile, G., Bergamin, S., Rizzo, S., Dolcetti, R., & Rossi, A. D. (2008) · Journal of Virology · doi:10.1128/jvi.00321-08 · Cited by 88
Bertorelle, R., Briarava, M., Rampazzo, E., Biasini, L., Agostini, M., Maretto, I., Lonardi, S., Friso, M. L., Mescoli, C., Zagonel, V, et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.602 · Cited by 77
Lung alveolar integrity is compromised by telomere shortening in telomerase-null mice
Lee, J., Reddy, R., Barsky, L., Scholes, J., Chen, H., Shi, W., & Driscoll, B. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90411.2008 · Cited by 75
Rampazzo, E., Bonaldi, L., Trentin, L., Visco, C., Keppel, S., Giunco, S., Frezzato, F., Facco, M., Novella, E., Giaretta, I., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.049874 · Cited by 66
Lamins as mediators of oxidative stress
Sieprath, T., Darwiche, R., & Vos, W. H. D. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.04.058 · Cited by 76
Renaud, S., Loukinov, D. I., Alberti, L., Vostrov, A. A., Kwon, Y., Bosman, F. T., Lobanenkov, V. V., & Benhattar, J. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq827 · Cited by 71
hTERT promotes cell adhesion and migration independent of telomerase activity
Liu, H., Liu, Q., Ge, Y., Zhao, Q., Zheng, X., & Zhao, Y. B. (2016) · Scientific Reports · doi:10.1038/srep22886 · Cited by 76
Shim, G., Ricoul, M., Hempel, W. M., Azzam, E. I., & Sabatier, L. (2014) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2014.01.001 · Cited by 74
Self-citationHTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches
Taylor, J. M., & Nicot, C. (2008) · APOPTOSIS · doi:10.1007/s10495-008-0208-7 · Cited by 69
Telomeres, senescence, and hematopoietic stem cells
Zimmermann, S., & Martens, U. M. (2007) · Cell and Tissue Research · doi:10.1007/s00441-007-0469-4 · Cited by 72
Kesäniemi, J., Lavrinienko, A., Tukalenko, E., Boratyński, Z., Kivisaari, K., Mappes, T., Milinevsky, G. P., Møller, A. P., Mousseau, T. A., & Watts, P. C. (2019) · Scientific Reports · doi:10.1038/s41598-018-37164-8 · Cited by 69
Telomeres and telomerase as targets for cancer therapy
Zimmermann, S., & Martens, U. M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6481-8 · Cited by 71
Telomerase reverse transcriptase in the regulation of gene expression
Zhou, J., Ding, D., Wang, M., & Cong, Y. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.1.284 · Cited by 63
Kawano, Y., Kim, H. T., Matsuoka, K., Bascug, G., McDonough, S. M., Ho, V. T., Cutler, C. S., Koreth, J., Alyea, E. P., Antin, J. H., et al. (2011) · Blood · doi:10.1182/blood-2011-06-362137 · Cited by 63
Human telomerase expression regulation
Machnik, M., Wojtyla, A., & Rubiś, B. (2011) · Biochemistry and Cell Biology · doi:10.1139/o11-037 · Cited by 62
The inhibitory effect of Curcuma longa extract on telomerase activity in A549 lung cancer cell line
Pourhassan, M., Zarghami, N., Rahmati, M., Alibakhshi, A., & Ranjbari, J. (2010) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb09.904 · Cited by 59
The human telomere and its relationship to human disease, therapy, and tissue engineering
Moon, I. (2007) · Frontiers in Bioscience · doi:10.2741/2412 · Cited by 54
Jin, X., Beck, S. J., Sohn, Y.-W., Kim, J.-K., Kim, S.-H., Yin, J., Pian, X., Kim, S.-C., Choi, Y.-J., & Kim, H. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.8.058 · Cited by 55
Lamy, E., Herz, C., Lutz‐Bonengel, S., Hertrampf, A., Márton, M.-R., & Mersch‐Sundermann, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053240 · Cited by 54
Iannilli, F., Zalfa, F., Gartner, A., Bagni, C., & Dotti, C. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066602 · Cited by 53
Telomerase as a useful target in cancer fighting—the breast cancer case
Hołysz, H., Lipińska, N., Paszel-Jaworska, A., & Rubiś, B. (2013) · Tumor Biology · doi:10.1007/s13277-013-0757-4 · Cited by 56
Telomerase Deficiency Affects Normal Brain Functions in Mice
Lee, J., Jo, Y. S., Sung, Y. H., Hwang, I. K., Kim, H., Kim, S., Yi, S. S., Choi, J.-S., Sun, W., Seong, J. K., et al. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0044-3 · Cited by 52
Wu, X., Huang, C., He, X., Tian, Y., Zhou, D., He, Y., Liu, X., & Li, J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.08.009 · Cited by 54
Non-telomeric activities of telomerase
Majerská, J., Sýkorová, E., & Fajkus, J. (2011) · Molecular BioSystems · doi:10.1039/c0mb00268b · Cited by 48
Liu, X., Huang, H., Wang, J., Wang, C., Wang, M., Zhang, B., & Pan, C. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.03.017 · Cited by 47
Crespo, D., Bonnet, É., Roher, N., MacKenzie, S. A., Krasnov, A., Goetz, F. W., Bobe, J., & Planas, J. V. (2010) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-8-34 · Cited by 49
Implications of telomeres and telomerase in endometrial pathology
Hapangama, D. K., Kamal, A., & Saretzki, G. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw044 · Cited by 43
The neuroprotective role and mechanisms of TERT in neurons with oxygen–glucose deprivation
Li, J., Qu, Y., Chen, D., Zhang, L., Zhao, F., Luo, L., Pan, L., Hua, J., & Mu, D. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.015 · Cited by 45
The Role of Telomerase in Breast Cancer’s Response to Therapy
Judasz, E., Lisiak, N., Kopczyński, P., Taube, M., & Rubiś, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112844 · Cited by 47
Dinami, R., Buemi, V., Sestito, R., Zappone, A., Ciani, Y., Mano, M., Petti, E., Sacconi, A., Blandino, G., Giacca, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21180 · Cited by 42
Ma, J., Xu, R.-J., Ju, X., Wang, W.-H., Luo, Z., Liu, C., Yang, L., Li, B., Chen, J., Meng, B., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0419-19.2019 · Cited by 45
Xiao, Z., Zhang, A., Lin, J., Zheng, Z., Shi, X., Di, W., Qi, W., Zhu, Y., Zhou, G., & Fang, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101251 · Cited by 45
Uziel, O., Beery, E., Dronichev, V., Samocha, K., Gryaznov, S. M., Weiss, L., Slavin, S., Kushnir, M., Nordenberg, Y., Rabinowitz, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009132 · Cited by 44
The isoprenoid perillyl alcohol inhibits telomerase activity in prostate cancer cells
Sundin, T., Peffley, D. M., Gauthier, D. T., & Hentosh, P. (2012) · Biochimie · doi:10.1016/j.biochi.2012.07.028 · Cited by 41
PML-IV functions as a negative regulator of telomerase by interacting with TERT
Oh, W., Ghim, J., Lee, E., Yang, M.-R., Kim, E. T., Ahn, J.-H., & Song, J. (2009) · Journal of Cell Science · doi:10.1242/jcs.048066 · Cited by 43
Lagadari, M., Zgajnar, N. R., Gallo, L. I., & Galigniana, M. D. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.05.002 · Cited by 38
RetractedDastmalchi, N., Safaralizadeh, R., Baradaran, B., Hosseinpourfeizi, M., & Baghbanzadeh, A. (2019) · Gene · doi:10.1016/j.gene.2019.144301 · Cited by 38
Terrin, L., Dolcetti, R., Corradini, I., Indraccolo, S., Col, J. D., Bertorelle, R., Bonaldi, L., Esposito, G., & Rossi, A. D. (2007) · International Journal of Cancer · doi:10.1002/ijc.22661 · Cited by 42
Shin, W. H., & Chung, K. C. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2641-7 · Cited by 38
hTERT: Another brick in the wall of cancer cells
Lamy, E., Goetz, V., Erlacher, M., Herz, C., & Mersch‐Sundermann, V. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.12.005 · Cited by 38
Mattiussi, M., Tilman, G., Lenglez, S., & Decottignies, A. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.11.004 · Cited by 37
Qu, Y., Duan, Z., Zhao, F., Wei, D., Zhang, J., Tang, B., Li, J., Yang, C., & Mu, D. (2011) · Stroke · doi:10.1161/strokeaha.111.626325 · Cited by 36
RetractedTelomerase and its extracurricular activities
Jaiswal, R. K., Kumar, P., & Yadava, P. K. (2013) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-013-0105-0 · Cited by 38
Telomere protein complexes and interactions with telomerase in telomere maintenance
Pinto, A. R., Li, H., Nicholls, C., & Liu, J. (2010) · Frontiers in bioscience · doi:10.2741/3683 · Cited by 40
Dolcetti, R., & De Rossi, A. (2012) · Medicinal Research Reviews · doi:10.1002/med.20211 · Cited by 35
Kong, W., Lv, N., Wysham, W. Z., Roque, D. R., Zhang, T., Jiao, S., Song, D., Chen, J., Bae-Jump, V. L., & Zhou, C. (2015) · Journal of Cancer · doi:10.7150/jca.13054 · Cited by 36
Karmakar, S., Banik, N. L., & Ray, S. K. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9369-y · Cited by 34
Indran, I. R., Hande, M. P., & Pervaiz, S. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.12.001 · Cited by 36
A Truncated Form of p23 Down-regulates Telomerase Activity via Disruption of Hsp90 Function
Woo, S. H., An, S., Lee, H.-C., Jin, H.-O., Seo, S., Yoo, D., Lee, K. H., Rhee, C. H., Choi, E., Hong, S.-I., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.052720 · Cited by 35
Herz, C., Hertrampf, A., Zimmermann, S., Stetter, N., Wagner, M., Kleinhans, C., Erlacher, M., Schüler, J. B., Platz, S., Rohn, S., et al. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12412 · Cited by 33
Ets2 transcription factor, telomerase activity and breast cancer
Dwyer, J., & Liu, J. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05236.x · Cited by 37
Ameri, Z., Ghiasi, S., Farsinejad, A., Hassanshahi, G., Ehsan, M., & Fatemi, A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.04.060 · Cited by 32
Fatemi, A., Safa, M., & Kazemi, A. (2015) · Tumor Biology · doi:10.1007/s13277-015-3575-z · Cited by 34
The Apaf-1-binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptotic potential
Melzer, I. M., Fernández, S. B. M., Bösser, S., Lohrig, K., Lewandrowski, U., Wolters, D. A., Kehrloesser, S., Brezniceanu, M.-L., Theos, A. C., Irusta, P. M., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.17 · Cited by 31
Multiple Actions of Telomerase Reverse Transcriptase in Cell Death Regulation
Palamarchuk, A. I., Kovalenko, E. I., & Streltsova, M. A. (2023) · Biomedicines · doi:10.3390/biomedicines11041091 · Cited by 35
Li, J., Tang, B., Qu, Y., & Mu, D. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2011.07.010 · Cited by 30
Noureini, S. K., & Wink, M. (2015) · Molecules · doi:10.3390/molecules20033730 · Cited by 30
Folini, M., Bandiera, R., Millo, E., Gandellini, P., Sozzi, G., Gasparini, P., Longoni, N., Binda, M., Daidone, M. G., Berg, K., et al. (2007) · Cell Proliferation · doi:10.1111/j.1365-2184.2007.00470.x · Cited by 30
Human Telomerase Reverse Transcriptase (hTERT) Positively Regulates 26S Proteasome Activity
Im, E., Yoon, J. B., Lee, H., & Chung, K. C. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25607 · Cited by 28
Liu, T., Liang, X., Li, B., Björkholm, M., Jia, J., & Xu, D. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.208 · Cited by 29
Telomere attrition in lens epithelial cells - a target for N-acetylcarnosine therapy
Mark, A. B. (2010) · Frontiers in bioscience · doi:10.2741/3655 · Cited by 29
Patented therapeutic approaches targeting LRP/LR for cancer treatment
Vania, L., Morris, G., Otgaar, T. C., Bignoux, M. J., Bernert, M., Burns, J., Gabathuse, A., Singh, E., Ferreira, E., & Weiss, S. F. T. (2019) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2019.1693543 · Cited by 27
Many Functions of Telomerase Components: Certainties, Doubts, and Inconsistencies
Udroiu, I., Marinaccio, J., & Sgura, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315189 · Cited by 26
Bollmann, F. M. (2013) · Biochimie · doi:10.1016/j.biochi.2013.07.031 · Cited by 31
Role for Telomerase in Listeria monocytogenes Infection
Samba‐Louaka, A., Stavru, F., & Cossart, P. (2012) · Infection and Immunity · doi:10.1128/iai.00614-12 · Cited by 25
Vafaiyan, Z., Gharaei, R., & Asadi, J. (2015) · Europe PMC (PubMed Central) · Cited by 21
Liu, Y., Betori, R. C., Pagacz, J., Frost, G. B., Efimova, E. V., Wu, D., Wolfgeher, D. J., Bryan, T. M., Cohen, S. B., Scheidt, K. A., et al. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.09.002 · Cited by 24
Wang, F.-Z., Li, S., Ye, L., & Zhang, X. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00729.x · Cited by 21
Ojeda, D. S., López‐Costa, J. J., Sede, M. M., López, E. M., Berría, M. I., & Quarleri, J. F. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23294 · Cited by 19
Uziel, O., Yosef, N., Sharan, R., Ruppin, E., Kupiec, M., Kushnir, M., Beery, E., Cohen-Diker, T., Nordenberg, J., & Lahav, M. (2014) · Genomics · doi:10.1016/j.ygeno.2014.10.013 · Cited by 19
YAP1-mediated regulation of mitochondrial dynamics in IDH1 mutant gliomas
Patrick, S., Gowda, P., Lathoria, K., Suri, V. S., & Sen, E. (2021) · Journal of Cell Science · doi:10.1242/jcs.259188 · Cited by 18
Wang, F., Fu, P., Pang, Y., Liu, C., Shao, Z., Zhu, J., Li, J., Wang, T., Zhang, X., & Liu, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-1611-z · Cited by 17
Pestana, A., Batısta, R., Celestino, R., Canberk, Ş., Sobrinho-Simões, M. A., & Soares, P. (2020) · Cancers · doi:10.3390/cancers12071846 · Cited by 15
Telomerase Reverse Transcriptase Contains a BH3-Like Motif and Interacts with BCL-2 Family Members.
Jin, Y., You, L., Kim, H. J., & Lee, H. (2018) · PubMed Central · doi:10.14348/molcells.2018.0206 · Cited by 17
Folini, M., Pennati, M., & Zaffaroni, N. (2008) · Methods in molecular biology · doi:10.1007/978-1-60327-547-7_15 · Cited by 14
Qian, X., Cheng, J. Q., Chen, A., Wang, Y., Tao, Y., Cao, J., & Feng, Z. (2008) · Oncology Reports · doi:10.3892/or.19.2.575 · Cited by 12
Metadata
- Authors
- Massard, C., Zermati, Y., Pauleau, A.-L., Larochette, N., Métivier, D., Sabatier, L., Kroemer, G., & Soria, J.-C.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- Corresponding author
- Kroemer, G
- Soria, J-C
- Venue
- Oncogene
- Published
- 2006-04-17
- Volume
- 25
- Issue
- 33
- Pages
- 4505-4514
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1486872926
- Cited by
- 144
- References
- 57
- Citations by year
- 2026: 3 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 1 · 2020: 3 · 2019: 7 · 2018: 3 · 2017: 5 · 2016: 6 · 2015: 6 · 2014: 12 · 2013: 17 · 2012: 11
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Update notices
- erratum (2013-01-24)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Commission
- Ligue Contre le Cancer
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- hTERT, telomerase, mitochondrial apoptosis, Bax, Bcl-2 family proteins, p53, chemosensitization, reactive oxygen species, mitochondrial membrane permeabilization, cervical cancer, colon cancer, siRNA knockdown
- MeSH terms
- Antineoplastic Agents, Cell Survival, Uterine Cervical Neoplasms, Cisplatin, Colonic Neoplasms, DNA-Binding Proteins, Etoposide, Female, Humans, Mitochondria, Mitomycin, Apoptosis, Reactive Oxygen Species, fas Receptor, Telomerase, Catalytic Domain, Cell Line, Tumor, bcl-2-Associated X Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.